Masur H., Ognibene FP, Yarchoan R., et al: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med111:223-231, 1989
2.
Wharton JM, Coleman DL, Wofsy CB, et al: Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med105:37-44, 1986
3.
Sattler FR, Cowan R., Nielsen DM, et al: Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med109:280-287, 1988
4.
Medina I., Mills J., Leoung G., et al: Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med323:776-782, 1990
5.
Ruf B., Rohde I., Pohle HD: Efficacy of clindamycin/ primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia. Eur J Clin Microbiol Infect Dis10:207-210, 1991
6.
Allegra C., Chabner BA, Tuazon CU, et al: Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med317:987-985,1987
7.
Sattler FR, Allegra CJ, Verdegem TD, et al: Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia. J Infect Dis161:91-96, 1990
8.
Hughes WT, Kennedy W., Shenep JL, et al: Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneunocystis carinii activity: A phase I study in human imunodeficiency virus (HIV)-infected men. J Infect Dis163:843-848, 1991
9.
Falloon J., Hughes W., Lancaster D., et al: 566C80 for the treatment of Pneumocystis carinii pneumonia in AIDS. VII International Conference on AIDS. W.B.2239, 1991 (abstr)
10.
Soo Hoo GW, Mohsenifar Z., Meyer RD: Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. Ann Intern Med113:195-202, 1990
11.
Conte JE Jr , Chernoff D., Feigal DW, et al: Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. Ann Intern Med113:203-209, 1990
12.
Bozzette SA , Sattler FR, Chiu J., et al: A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med323:1451-1457, 1990
13.
National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia: Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med323:1500-1504,1990
14.
Hughes WT, Kuhn S., Chaudhary S., et al: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis . N Engl J Med297:1419-1426, 1977
15.
Fischl MA, Dickinson GM, La Voie L.: Safety and efficacy of sulmethoxazole and trimethoprim chemoprophlaxis for Pneumocystis carinii pneumonia in AIDS. JAMA259:1185-1189,1988
16.
Hirschel B. , Lazzarin A., Chopard P., et al: A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med324:1079-1083, 1991
17.
Montaner JS , Lindsay ML, Gervais A., et al: Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. Ann Intern Med114:948-953, 1991
18.
Sullivan LW: HHS News. Office of Communication, National Institutes of Allergy and Infectious Diseases, Bethesda, MD, September 6, 1991 (press release)
19.
Mallolas J. , Zamora L., Gatell JM, et al: Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pueumocystis carinii pneumonia. Lancet337:1162-1163, 1991
20.
Leport C., Raffi F., Matheron S., et al: Treatment of central nervous system toxoplasmosis with pyrimethamine/ sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Am J Med84:94-100,1988
21.
Dannemann BR , Israelski DM, Remington JS: Treatment of toxoplasmic encephalitis with intravenous clindamycin. Ann Intern Med148:2477-2482, 1988
22.
Rolston Kvi : Treatment of acute toxoplasmosis with oral clindamycin. Eur J Clin Microbiol Infect Dis10:181-183,1991
23.
Foppa CU, Bini T., Gregis G., et al: A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis10:187-189, 1991
24.
Katlama C.: Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS . Eur J Clin Microbiol Infect Dis10:189-191, 1991
25.
Dannemann BR , McCutchan JA, Israelski DM, et al: Treatment of acute toxoplasmosis with intravenous clindamycin. Eur J Clin Microbiol Infect Dis10:193-195, 1991
26.
Masur H., O'Neill D., Feuerstein I., et al: 566C80 is effective as salvage treatment for toxoplasma encephalitis . VII International Conference on AIDS, W.B.31, 1991 (abstr)
27.
Jacobson MA , Besch CL, Child R., et al: Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection . Eur J Clin Microbiol Infect Dis10:195-198, 1991
28.
Derouin G., Chastang C.: Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine. J Antimicrob Chemother25:708-711, 1990
29.
Chang HR, Rudareanu FC, Pechère J-C.: Activity of A-56268 (TE-031), a new macrolide, against toxoplasma gondii in mice. J Antimicrob Chemother22:359-361, 1988
30.
Araujo FG, Guptill DR, Remington JS: Azithromycin, a macrolide antibiotic with potent activity against toxoplasma gondii. Antimicrob Agents Chemother32:755-757, 1988
31.
Rolston Kvi , Fainstein V., Bodey GP: Intestinal cryptosporidiosis treated with eflornithine: A prospective study among patients with AIDS. J AIDS2:426-430, 1989
32.
Portnoy D., Whiteside ME, Buckley E., et al: Treatment of intestinal cryptosporidiosis with spiramycin. Ann Intern Med101:202-204, 1984
33.
Connolly GM , Youle M., Gazzard BG: Diclazuril in the treatment of severe cryptosporidial diarrhea in AIDS patients. AIDS4:700-701, 1990
34.
Nord J., Ma P., DiJohn D., et al: Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS4:581-584, 1990
35.
Pon D., Dong BJ: DIAS rounds: Drug information analysis service. DICP ( Ann Pharmacother) 24:951-952, 1990
36.
Simon D., Weiss L., Tanowitz HB, et al: Resolution of Cryptosporidium infection in an AIDS patient after improvement of nutritional and immune status with octreotide. Am J Gastroenterol86:615-618, 1991
37.
Gathe J., Piot D., Bernal A., et al: The effectiveness of paromomycin in the treatment of gastrointestinal cryptosporidiosis (GIC). VII International Conference on AIDS, M.B.2270, 1991 (abstr)
38.
Bennett JE, Dismukes WE, Duma RJ, et al: A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med301:126-131, 1979
39.
Chuck SL, Sande MA: Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome . N Engl J Med321:794-799, 1989
40.
Larsen RA, Leal AE, Chan LS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med113:183-187, 1990
41.
Denning DW, Tucker RM, Hanson LH, et al: Itraconazole therapy for cryptococcal meningitis and cryptococcosis . Arch Intern Med149:2301-2308, 1989
42.
Bozzette SA , Larsen RA, Chiu J., et al: A placebocontrolled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med324:580-584, 1991
43.
Bennett JE: Antifungal agents, in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practice of Infectious Diseases (ed 3). New York, NY, Churchill Livingstone, 1990, pp 361-370
44.
Koletar SL, Russell JA, Fass RJ, et al: Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus . Antimicrob Agents Chemother34:2267-2268, 1990
45.
DeWit S., Weerts D., Goossens H., et al: Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet1:746-747, 1989
46.
Chiu J., Nussbaum J., Bozzette S., et al: Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med113:358-361, 1990
47.
Agins BD, Berman DS, Spicehandler D., et al: Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis159:784-787, 1989
48.
Hoy J., Mijch A., Sandland M., et al: Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis161:801-805, 1990
49.
Fernandes PB , Hardy DJ, McDaniel D., et al: In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother33:1531-1534, 1989
50.
Inderlied CB , Kolonski PT, Wu M., et al: In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis159:994-997, 1989
51.
Prokocimer P., Dellerson M., Craft C., et al: Effect of clarithromycin (C) on blood cultures (BC) positive for mycobacterium avium complex (MAC) in HIV+ patients (Pts). ICAAC, 1990, p 192 (abstr 634)
52.
Dautzenberg B., Legris S., Truffot C., et al: Clarithromycin clear mycobacterium avium intracellulare (MAIC) from blood of AIDS patients . ICAAC, 1990, p 297 (abstr 1264)
53.
Buhles WC, Mastre BJ, Tinker AJ, et al: Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients. Rev Infect Dis10:S495-S506, 1988 (suppl)
54.
Masur H., Lane HC, Palestine A., et al: Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Intern Med10-1:41-44, 1986
55.
Reed EC, Bowden RA, Dandliker PS, et al: Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants . Ann Intern Med109:783-788,1988
56.
Palestine AG , Polis MA, DeSmet M., et al: A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS . Ann Intern Med115:665-673, 1991
57.
Jacobson MA , Drew WL, Feinberg J., et al: Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis163:1348-1351, 1991
58.
Straus SE, Smith HA, Brickman C., et al: Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med96:270-277, 1982
59.
Safrin S., Crumpacker C., Chatis P., et al: A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simples in the acquired immunodeficiency syndrome. N Engl J Med325:551-555, 1991
60.
Jacobson MA , Berger TG, Fikrig S., et al: Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med112:187-191, 1990
61.
Safrin S., Berger TG, Gilson I., et al: Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med115:19-21, 1991
